The nascent field of AllergoOncology Erika Jensen-JarolimGraham Pawelec Editorial 22 August 2012 Pages: 1355 - 1357
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes Monica BernalFrancisco Ruiz-CabelloFederico Garrido Review 26 July 2012 Pages: 1359 - 1371
Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth Matthew R. PorembkaJonathan B. MitchemPeter Goedegebuure Original article 04 January 2012 Pages: 1373 - 1385
Photodynamic therapy–generated cancer vaccine elicits acute phase and hormonal response in treated mice Mladen KorbelikSoroush Merchant Original Article 24 January 2012 Pages: 1387 - 1394
IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients B. SchillingE. S. HalsteadT. L. Whiteside Original Article 20 January 2012 Pages: 1395 - 1405
Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma Nicolai LeonhartsbergerReinhold RamonerMartin Thurnher Original Article 26 January 2012 Pages: 1407 - 1413
Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer Chun-Jian QiYong-Ling NingKe-Qing Qian Original article 31 January 2012 Pages: 1415 - 1424
Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma Keisuke KohgaTomohide TatsumiTetsuo Takehara Original Article 01 February 2012 Pages: 1425 - 1432
Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma Shan RenJunfeng LuLai Wei Original Article 04 February 2012 Pages: 1433 - 1439
Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice Pierre L. TriozziWayne AldrichYogen Saunthararajah Original Article 05 February 2012 Pages: 1441 - 1450
Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor Christiane SahmKurt SchönfeldWinfried S. Wels Original article 05 February 2012 Pages: 1451 - 1461
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer Sandra SalviVincenzo FontanaMaria Pia Pistillo Original article 09 February 2012 Pages: 1463 - 1472
IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells Ute E. BurkhardtArjen SlootsWinfried S. Wels Original article 14 February 2012 Pages: 1473 - 1484
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions Peggy J. de Vos van SteenwijkTamara H. RamwadhdoebeSjoerd H. van der Burg Short communication Open access 09 June 2012 Pages: 1485 - 1492
Epidemiology: allergy history, IgE, and cancer Michelle C. Turner Symposium-in-writing paper 20 December 2011 Pages: 1493 - 1510
The roles of mast cells in anticancer immunity Dyana K. DaltonRandolph J. Noelle Symposium-in-writing paper 18 April 2012 Pages: 1511 - 1520
How to connect an IgE-driven response with CTL activity? Barbara PlatzerEleonora DehlinkEdda Fiebiger Symposium-in-writing paper 01 November 2011 Pages: 1521 - 1525
Involvement of eosinophils in the anti-tumor response Solène GataultFanny LegrandMonique Capron Symposium-in-writing paper 17 June 2012 Pages: 1527 - 1534
Animal models for IgE-meditated cancer immunotherapy Tracy R. DanielsOtoniel Martínez-MazaManuel L. Penichet Symposium-in-writing paper 23 December 2011 Pages: 1535 - 1546
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application Sophia N. KaragiannisDebra H. JosephsHannah J. Gould Symposium-in-writing paper 03 December 2011 Pages: 1547 - 1564
Recombinant IgE antibody engineering to target EGFR Edzard SpillnerMelanie PlumIngke Braren Symposium-in-writing paper 07 June 2012 Pages: 1565 - 1573
Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization Mariana CastellsMaria del Carmen Sancho-SerraMaria Simarro Symposium-in-writing paper 11 May 2012 Pages: 1575 - 1584
Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer Diana MechtcheriakovaMartin SvobodaErika Jensen-Jarolim Symposium-in-writing paper Open access 19 April 2012 Pages: 1591 - 1598
Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19–22, 2011: New perspectives in the immunotherapy of cancer Michele MaioHugues J. M. Nicolayon behalf of NIBIT Meeting report 27 June 2012 Pages: 1599 - 1608